Tamiflu: the battle for key drug information. Influenza drug oseltamivir has made billions

Tamiflu: the battle for key drug information. Influenza drug oseltamivir has made billions Influenza drug oseltamivir has made vast amounts of pounds for Roche, but why won’t the organization give patients and physicians usage of the total data that are clinical? Included in the BMJ’s open information campaign, we this week introduce a brand new […]